A bipartisan group of lawmakers have filed a new bill in Congress what would require the Department of Defense to evaluate how ongoing research on the therapeutic benefits of psilocybin could help members of the military.
The Veterans and Servicemembers PTSD Emerging Treatment Review Act, filed this week by Rep. Abe Hamadeh (R-AZ), would direct the assistant secretary of defense for health affairs to coordinate with other federal officials to issue a report on how the results of study on psychedelic mushrooms that is currently being carried out in Arizona could “apply to members of the Armed Forces, including such members transitioning to civilian life.”
The report, due within 180 days of the legislation being enacted, would need to include “a summary of the safety, dosing, and adverse event data” from the research as well as “an assessment of the implications of such data for force health protection, medical readiness, and suicide prevention strategies.”
Officials would also need to describe “legal and regulatory requirements for any potential expanded access pathway involving an investigational Schedule I substance” and provide an assessment of the applicability of the federal Right to Try law and a psychedelics executive order signed by President Donald Trump for
Read full article on Marijuana Moment
